MedPath

The Effectiveness of Sublingual or Oral Administration Misoprostol for Cervical Ripening before Manual Vacuum Aspiration in First Trimester Termination of Pregnancy: Randomized Controlled Trial

Phase 3
Completed
Conditions
First trimester termination of pregnancyThe effectiveness of Misoprostol for cervical preparation before manual vacuum aspiration
first trimester abortion
misoprostol
cervical dilatation
manual vacuum aspiration
Registration Number
TCTR20140427001
Lead Sponsor
Faculty of medicine, Thammasat University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
80
Inclusion Criteria

A singleton intrauterine pregnancy equal or less than 12 weeks gestational age with a diagnosis of early pregnancy failure blighted ovum anembryonic gestation and embryonic death no cardiac activity visible on TVS when the embryo measures 5 mm or more in length The gestational age was verified by a reliable menstrual history and confirmed by physical or ultrasound examination

Exclusion Criteria

A history of misoprostol allergy
anticoagulant usage
clinical coagulopathy
bleeding disorder
hypertension
chronic illness
active pelvic inflammatory disease
inevitable and incomplete abortion

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
cervical dilatation was measured prior to Manual Vacuum Aspiration The cervical width was measured prior to Manual Vacuum Aspiration cervical width was measured by largest Hegar’s dilators that pass through cervix without resistance
Secondary Outcome Measures
NameTimeMethod
pain scores and patient satisfactions after finished manual vacuum aspiration visual analogue 10cm-scale with zero to 10
© Copyright 2025. All Rights Reserved by MedPath